Xue, M., Wu, Y., Tang, Y., Huang, K., Liu, H., Zhu, B., . . . Li, J. Efficacy and safety of TACE combined with lenvatinib and PD-1 Inhibitor in intermediate-stage HCC exceeding the up-7 criteria: A retrospective cohort study. Frontiers Media S.A.
Chicago Style (17th ed.) CitationXue, Miao, et al. Efficacy and Safety of TACE Combined with Lenvatinib and PD-1 Inhibitor in Intermediate-stage HCC Exceeding the Up-7 Criteria: A Retrospective Cohort Study. Frontiers Media S.A.
MLA (9th ed.) CitationXue, Miao, et al. Efficacy and Safety of TACE Combined with Lenvatinib and PD-1 Inhibitor in Intermediate-stage HCC Exceeding the Up-7 Criteria: A Retrospective Cohort Study. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.